Telithromycin, which is the representative of ketolides, has come into market in 2001. It shows very good activity against some macrolide-resistant bacteria.
酮内酯中最具代表性的药物泰利霉素已于2001年成功上市，其对包括大环内酯耐药菌在内的革兰氏阳性菌具有良好的抗菌活性。
The invention concerns a novel therapeutic application of ketolides for preparing pharmaceutical compositions for preventing arterial thrombotic complications related to atherosclerosis.
本发明涉及酮立得在制备用于预防与动脉粥样硬化有关的动脉栓塞并发症的药物组合物中的新治疗应用。
The invention concerns a novel therapeutic application of ketolides for preparing pharmaceutical compositions for preventing arterial thrombotic complications related to atherosclerosis.
本发明涉及酮立得在制备用于预防与动脉粥样硬化有关的动脉栓塞并发症的药物组合物中的新治疗应用。
应用推荐